Back to Search
Start Over
Supplementary Figure S2 from Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure S2 shows that EVT801 inhibits tubule formation
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....037736354b4256c19454a11e4ae159d6
- Full Text :
- https://doi.org/10.1158/2767-9764.22546326